Michael Mina

Mina, MD, PhD, is the Chief Science Officer of eMed. He was previously assistant professor of epidemiology and immunology/infectious diseases at the Harvard T.H. Chan School of Public Health, Center for Communicable Disease Dynamics; and associate medical director in clinical microbiology at the Brigham and Women’s Hospital.

Recent Articles

We’re Not Testing Enough for Bird Flu

The most important tool in our arsenal is widespread testing, write Janika Schmitt and Michael Mina. We're not doing enough of it.

By Michael Mina and Janika Schmitt

The Key Policy We Need to End the Pandemic Is Being Ignored

The goal is clearly articulated in President Joe Biden’s State of the Union address: Test to Treat. He challenged America to “get back to work and fill our great downtowns again.” He was no longer...

By Steven Phillips and Michael Mina

How to Make COVID-19 Testing for Travel Far More Effective

After nearly 2 years of calling for rapid tests, the U.S. is finally catching up to the rest of the world with these crucial public health tools. There is no time better than now, as...

By Michael Mina

America Needs an Operation Warp Speed for Rapid COVID Testing

The Delta variant has caused a resurgence in COVID-19 cases and deaths, threatening earlier gains made by the Biden Administration in tackling the pandemic. President Biden on Thursday laid out an ambitious comprehensive six-point COVID...

By Michael Mina and Steven Phillips

Why We Still Need Widespread Rapid Testing Even With Vaccines

The vaccines are here. Why do we still need testing? Testing is our eye on the virus. Without testing, we can’t see where it is or where it is going. As fall and winter set...

By Michael Mina

How We Can Stop the Spread of Coronavirus

We are at war with a virus that is currently winning by taking two 9/11’s worth of victims every week—by Christmas it could be three. There is no question that if 1,000 Americans were dying...

By Michael Mina
More from TIME
More From TIME